Monoclonal Antibody Therapy

If you’ve recently tested positive for COVID-19 how you can reduce your risk of becoming sicker? Dr Nancy’s Integrative Medicine is here to help you by offering Monoclonal Antibody Therapy.

The goal of this therapy is to help prevent hospitalizations, reduce viral loads and lessen symptom severity. The FDA has authorized the emergency use of monoclonal antibody therapy for the treatment of COVID-19 under an Emergency Use Authorization (EUA) for people 12 years of age or older.

Monoclonal antibodies are laboratory-made proteins that mimic the body’s immune system to fight off COVID-19 infection. These antibodies are given to people directly through an intravenous (IV) infusion.

In multiple randomized controlled trials, high-risk outpatients with confirmed COVID-19 were 2 to 7% less likely to be hospitalized with severe COVID-19,” Spivak says. “This translates to these treated patients having a 70% to 80% reduced risk of hospitalization. The therapy does look to be highly effective if you give it to people at high risk of severe COVID-19 early in disease to prevent them from going to the hospital says Emily Spivak, MD, associate professor of medicine in the Division of Infectious Diseases at University of Utah Health